Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Bone Marrow Transplantation
|
October 23, 2012
Safety and efficacy of rituximab in steroid-refractory chronic GVHD
A Clavert, P Chevallier, T Guillaume, et al.
Leukemia
|
March 10, 2015
Impact of lenalidomide on immune functions in the setting of maintenance therapy for multiple myeloma
E Brissot, A Clavert, N Blin, et al.
Bone Marrow Transplantation
|
November 29, 2011
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity
T Guillaume, B Gaugler, P Chevallier, et al.
Bone Marrow Transplantation
|
March 12, 2014
Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
X Cahu, P Chevallier, A Clavert, et al.
Leukemia
|
February 28, 2013
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
F Damm, R Itzykson, O Kosmider, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C Soussain, S Choquet, M Blonski, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Bone Marrow Transplantation
|
October 23, 2012
Safety and efficacy of rituximab in steroid-refractory chronic GVHD
A Clavert, P Chevallier, T Guillaume, et al.
Leukemia
|
March 10, 2015
Impact of lenalidomide on immune functions in the setting of maintenance therapy for multiple myeloma
E Brissot, A Clavert, N Blin, et al.
Bone Marrow Transplantation
|
November 29, 2011
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity
T Guillaume, B Gaugler, P Chevallier, et al.
Bone Marrow Transplantation
|
March 12, 2014
Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
X Cahu, P Chevallier, A Clavert, et al.
Leukemia
|
February 28, 2013
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
F Damm, R Itzykson, O Kosmider, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C Soussain, S Choquet, M Blonski, et al.
Page
of 8